# OnCo record nct06072781 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06072781/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06072781", "NCT06072781" ;
  schema:name "A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer"@en ;
  schema:alternateName "RAMP 301"@en ;
  schema:description "A phase 3 trial of Pegylated liposomal doxorubicin, Paclitaxel / nab-paclitaxel, Letrozole in ovarian cancer, run by Verastem, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06072781/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06072781> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-03-18" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/low-grade-serous-ovarian-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/letrozole/> ;
  onco:companies <https://onco.cc/companies/verastem/> .